Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10963046 | Vaccine | 2015 | 8 Pages |
Abstract
For newborn hepatitis B vaccination in China, the 10 μg strategy should be cost-effective, even more possibly highly cost-effective or cost-saving compared with the current 5 μg strategy. The doses of 10 μg should be considered to replace the doses of 5 μg in newborn hepatitis B vaccination in China.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Juan Yin, Zhenhao Ji, Peifeng Liang, Qian Wu, Fuqiang Cui, Fuzhen Wang, Xiaofeng Liang, Guihua Zhuang,